Photobiomodulation therapy has important implications for health that many are still under-informed about. In this interview, photodynamic therapy researcher Michael Hamblin, Ph.D., who is an expert in this area, sets out to improve our understanding of this important field.
Hamblin is a researcher and associate professor of dermatology at Harvard Medical School. He’s also a principal investigator at The Wellman Center for Photomedicine at Massachusetts General Hospital, and a member of the Harvard-MIT Division of Health Sciences and Technology.
Infrared therapy is one aspect of photobiomodulation, which covers light of all wavelengths — visible light, and light from spectral regions including ultraviolet, blues through the green, red and into the near-, mid- and far-infrared wavelengths.
If you are interested in learning more about Photobiomodulation, please contact our office to make an appointment with Dr. Hotchner. (305) 856-8185